Publications by authors named "Barry Rodgers-Gray"

Claim this Profile
C
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in Canada.
Élisabeth Mercier, John R Fullarton, Bosco A Paes, Ian P Keary, Barry S Rodgers-Gray

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory syncytial virus immunization in children: The old, the new and what's just around the corner.
Bosco A Paes, Fabiana Bacchini, Marianne Bracht, Barry Rodgers-Gray, Xavier Carbonell-Estrany

Hum Vaccin Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of race on anti-PD-(L)1 monoclonal antibodies in non-small cell lung cancer: A systematic literature review and meta-analysis.
Carlo Genova, Federico Cappuzzo, Giorgio Minotti, Nicola Normanno, Barry Rodgers-Gray

Crit Rev Oncol Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Pandemic Dynamics of the Global Circulation of Human Metapneumovirus and Respiratory Syncytial Virus.
Marie-Noëlle Billard, Joanne G Wildenbeest, Ruben Kole, Barry Rodgers-Gray, John Fullarton

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce.
Paolo Manzoni, Eugenio Baraldi, Fabio Midulla, Olivier Claris, Sandro Dessardo, Barry Rodgers-Gray

Open Forum Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.
Xavier Carbonell-Estrany, Eric A F Simões, Louis Bont, Paolo Manzoni, Heather J Zar, Barry Rodgers-Gray

Expert Rev Anti Infect Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental Knowledge and Understanding of Respiratory Syncytial Virus and How to Decrease the Risk of Infection: The Canadian Premature Babies Foundation Survey 2023.
Marianne Bracht, Fabiana Bacchini, Barry Rodgers-Gray, James O Edwards, Bosco A Paes

Neonatal Netw· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants.
Ji-Man Kang, Xavier Carbonell-Estrany, Bosco Paes, Barry Rodgers-Gray, John Fullarton

Pediatr Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal Risk Factors for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Otherwise Healthy Preterm and Term Infants: A Systematic Review and Meta-analysis.
Paolo Manzoni, Elsa Viora, Marcello Lanari, Raffaella Iantomasi, Eva Agostina Montuori, Barry Rodgers-Gray

Pediatr Infect Dis J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective: the potential of wastewater-based surveillance as an economically feasible game changer in reducing the global burden of pediatric respiratory syncytial virus infection.
Nisha Thampi, Elisabeth Mercier, Bosco Paes, James O Edwards, Barry Rodgers-Gray

Front Public Health· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants.
Bosco Paes, Marcello Lanari, Barry Rodgers-Gray, John Fullarton, Xavier Carbonell-Estrany

Front Pediatr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.
Ian P Keary, Roberto Ravasio, John R Fullarton, Paolo Manzoni, Marcello Lanari, Barry Rodgers-Gray

PLoS One· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses.
Marianne Bracht, Barry Rodgers-Gray, Fabiana Bacchini, Bosco A Paes

Neonatal Netw· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurately Assessing the Expected Impact of Universal First Respiratory Syncytial Virus (RSV) Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants.
John Fullarton, Ian Keary, Bosco Paes, Jean-Eric Tarride, Xavier Carbonell-Estrany, Barry Rodgers-Gray

J Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infants.
Barry S Rodgers-Gray, John R Fullarton, Xavier Carbonell-Estrany, Ian P Keary, Jean-Éric Tarride

J Med Econ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries.
Xavier Carbonell-Estrany, Eric A F Simões, Louis J Bont, Angela Gentile, Nusrat Homaira, Barry S Rodgers-Gray

Front Pediatr· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of biosimilar pegfilgrastim in France: Economic analysis of switching from originator.
Patrick R Tilleul, Barry S Rodgers-Gray, James O Edwards

J Oncol Pharm Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoption in Canada of an international risk scoring tool to predict respiratory syncytial virus hospitalization in moderate-to-late preterm infants.
Bosco Paes, John R Fullarton, Barry S Rodgers-Gray, Xavier Carbonell-Estrany

Curr Med Res Opin· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries.
Xavier Carbonell-Estrany, Barry S Rodgers-Gray, Bosco Paes

Expert Rev Anti Infect Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical burden of severe respiratory syncytial virus infection during the first 2 years of life in children born between 2000 and 2011 in Scotland.
Richard Thwaites, Scot Buchan, John Fullarton, Carole Morris, ElizaBeth Grubb, Barry Rodgers-Gray

Eur J Pediatr· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between respiratory syncytial virus hospitalization in infancy and childhood asthma.
Jonathan Coutts, John Fullarton, Carole Morris, ElizaBeth Grubb, Scot Buchan, Barry Rodgers-Gray

Pediatr Pulmonol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IBD2020 global forum: results of an international patient survey on quality of care.
Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R Fullarton, Barry S Rodgers-Gray

Intest Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS]).
Xavier Carbonell-Estrany, Alberto Dall'Agnola, John R Fullarton, Barry S Rodgers-Gray, Elisa Girardi

Acta Paediatr· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants.
Maarten O Blanken, Bosco Paes, Evan J Anderson, Marcello Lanari, Margaret Sheridan-Pereira, Barry S Rodgers-Gray

Pediatr Pulmonol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.
Evan J Anderson, Xavier Carbonell-Estrany, Maarten Blanken, Marcello Lanari, Margaret Sheridan-Pereira, Barry Rodgers-Gray

Pediatr Infect Dis J· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis